Ocugen, Inc.
OCGNBiotechnology
$0.70−5.58%As of Oct 30vs prior close
- Market cap
- $238.3M
- From 52W high
- −71.67%
- EPS (YE23)
- -$0.26
- Revenue (LTM)
- $4.6M
- Net margin
- -1786.27%
- Dividend yield
- 0.00%
Nomior Score
21
Distressed LaggardSpeculativeBottom 8% of the scored universe
Growth60
Quality24
Value42
Momentum21
Resilience24
Growth
$4.6Mrevenue, LTM
YE16 $0LTM $4.6M
Connections
Revenue to profitQ2 YE26
The operating loss was 1105% of revenue, wider by 100 pts on a year.
Who owns it
2funds